Adam Chodorow

A front-page article in the Dec. 2 edition of The Arizona Republic about a U.S. Supreme Court case on a local company’s failure to inform investors about complaints against one of its products included comments from Professor Adam Chodorow of the Sandra Day O'Connor College of Law.

In “Scottsdale drugmaker case could change what companies tell investors,” reporter Ken Alltucker wrote that the key issue in the law suit against Matrixx Initiatives is whether it violated federal securities laws by not telling investors that some consumers complained of anosmia, or loss of smell, after certain nasal spray and gel swabs. Matrixx sells Zicam cold-and-flu products.

Chodorow said an adverse ruling from the Supreme Court, which will hear the case on Jan. 10, may prompt companies to disclose much more to investors, rather than risk being sued. This could result in investors having difficulty discerning what is important and what is not.

Companies may conclude “the only thing we can do to protect ourselves is to disclose everything,” Chodorow said.

Read the full article here.

Chodorow’s research and teaching interests lie in tax, administrative and regulatory law. He teaches a variety of tax courses, as well as Law and the Regulatory State. His research focuses on religious taxation and a variety of contemporary tax issues, such as the taxability of virtual income. Chodorow is Vice Chair for Planning for the Teaching Tax Committee of the ABA’s Tax Section and on the Council of the Tax Section of the State Bar of Arizona.